Téléversements by Gareth Macdonald

US FDA Form 483 to Aurobindo Pharma Ltd Unit VI

Draft Pharmaceutical Policy 2017

SB539_EN

1747636b-f890-4ff9-a976-1117dfc82300 filed by Wockhardt on 07 Mar 2017 17:45